Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. fastfinder

FastFinder

Artificial intelligence for automated, standardised interpretation of DNA testing results

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0
 Outcomes and results

 FastFinder project word cloud

Explore the words cloud of the FastFinder project. It provides you a very rough idea of what is the project "FastFinder" about.

leuven    tom    data    lab    uten    expenditure    automation    usp    university    decisions    pharma    427    biologists    2014    labs    treatment    gdp    cagr    contracted    algorithms    clinical    machine    fastfinder    chronic    dna    winning    health    extends    develops    personalised    coupled    centre    diagnostics    platform    highlights    projected    flanders    gain    times    boosting    24    standards    substantially    interpretation    stricter    disruptive    implications    led    company    solutions    venture    2060    commercial    innovative    scientists    clear    pressure    backed    record    ku    automated    track    bio    detection    start    5    9    solution    advancing    belgian    wouter    market    additional    workflow    revenue    diseases    costly    learning    grow    ugentec    business    45    tests    setting    award    healthcare    budgets    employees    intelligence    quality    serious    coming    removes    imec    ict    eic    errors    pull    demanding    2018    molecular    population    deloitte    standardised    capital    innovation    artificial    volumes    martens    automate    faster    microsoft    team    successful    skilled    human    engineers    patients    founded    hiring    ageing    public    continues    software    promotion    genetic    million    safety    manual    raised    food   

Project "FastFinder" data sheet

The following table provides information about the project.

Coordinator		 UGENTEC NV 

Organization address
address: KEMPISCHE STEENWEG 305/6
city: HASSELT
postcode: 3500
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country Belgium [BE]
 Project website http://www.ugentec.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
2. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2017
 Duration (year-month-day) from 2017-06-01   to  2017-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UGENTEC NV BE (HASSELT) coordinator 50˙000.00

Map

 Project objective

UgenTec is an award winning Belgian bio-IT start-up that develops software for automated and standardised analysis of DNA detection tests. Founded in 2014, it is venture backed and as raised a capital of €3.45 million. The company is led by Wouter Uten and Tom Martens, both with a track record in successful business development. UgenTec has a contracted revenue of €427.000, a team of 24 software engineers, data scientists and molecular biologists and is supported by Deloitte, IMEC, KU Leuven university, EIC-ICT labs and Microsoft Innovation Centre Flanders. Public health expenditure in the EU continues to rise with projected growth at 8.5% of GDP in 2060, driven by an ageing population and associated rise in chronic diseases and the promotion of personalised healthcare, demanding molecular information. This highlights an increasing need for automation in molecular diagnostics, including software solutions for interpretation of results. The market for genetic analysis software will grow substantially at 6.9% CAGR already by 2018. There is a clear market pull for automated solutions: as genetic testing volumes are growing every year and quality standards become stricter, the lab budgets are coming under pressure. As a disruptive innovative solution to this problem, UgenTec has developed the FastFinder software platform, advancing state of the art artificial intelligence and machine learning algorithms to automate the interpretation of results in the genetic testing workflow. FastFinder USP allows interpretation 30 times faster than manual interpretation and removes human errors that can lead to serious – and often costly – implications in treatment decisions for patients. Platform application potential extends beyond a clinical setting, (e.g. pharma, food safety) boosting commercial gain. This innovation has a revenue potential for UgenTec of over €100 million within 10 years coupled to the hiring of 100 additional highly skilled employees.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "FASTFINDER" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "FASTFINDER" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.1.1.;H2020-EU.2.3.1.)

REALM (2015)

A disruptive method to free physicians from Hospital Information Systems by generating fault free patient diagnostic documents in real-time using natural language

Read More  

Assist (2015)

Telocate ASSIST – Development and marketing of an acoustic solution for localization and navigation of people in buildings using the smartphone

Read More  

HYBCOPTER (2016)

Hybrid multi copter with 6 times more flight time.

Read More